Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PI-88 in Advanced Melanoma
NCT00068172Phase 2Completed
- Sponsor
- Cellxpert Biotechnology Corp.
- Start
- Jul 2001
- Primary completion
- Jun 2007
- Modality
- Bivalent/Multivalent Binders
- Countries
- 1
01
Overview
A Phase 2 trial of Muparfostat in melanoma, sponsored by Cellxpert Biotechnology Corp.. Started Jul 2001; status: completed.
02
Drugs
Muparfostat
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00068172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00068172.